American Well Corporation

AMWL Healthcare Health Information Services

American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024. In the quarter to June 2026, revenue fell 26.6%, EPS grew 52.4% and free cash flow grew 266.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

11.68 0.70 −5.65%
Market cap
$210.6M
P/E
0.0×
Fwd P/E
−2.6×
Dividend yield
—
F-score
6/9
Altman Z
−7.95
Beneish M
−3.29
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — 4 4 3 5 6
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — — 11.44 4.53 2.22 (4.56) (6.26) (7.95)
P/S ratio
— 0.00 0.00 10.23 6.07 2.79 1.59 0.43 0.32
Altman Z″-Score (non-manufacturers)
— — (2.45) 12.27 7.61 6.85 (9.04) (12.18) (16.00)
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Beneish M-Score
— — — (2.42) (2.03) (2.67) (7.12) (3.25) (3.29)
P/Operating CF
— (38.99) (38.99) (102.27) (34.16) (21.51) (9.91) (8.09) (4.54)
P/B ratio
— 0.00 0.00 2.01 1.22 0.71 0.86 0.34 0.32
Price to Tangible BV
— 0.00 0.00 2.52 2.31 1.51 1.15 0.51 0.43
EV/Sales
— 0.00 0.00 5.98 3.12 0.85 0.15 (0.47) (0.42)
EV/EBITDA
— 0.00 0.00 0.00 0.00 0.00 0.00 0.66 1.53
EV/Operating CF
— (6.08) (6.08) (13.04) (5.57) (1.22) (0.27) 0.94 1.57
EV/FCF
— (5.92) (5.92) (12.66) (5.55) (1.16) (0.25) 0.84 1.57
Quick Ratio
— 3.32 1.97 8.99 5.63 5.23 4.54 2.70 3.17
Current Ratio
— 3.39 2.10 9.20 5.84 5.49 4.79 2.85 3.37
Net Debt/EBITDA
— 5.37 2.09 4.85 4.65 2.18 1.68 1.26 2.69
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
— 0.00 0.60 0.26 0.18 0.21 0.29 0.50 0.66
Operating CF/Net income
— 1.41 0.94 0.50 0.80 0.71 0.22 0.61 0.69
Capex/Depreciation
— (0.29) (0.14) (0.27) (0.03) (0.37) (0.03) (0.42) 0.00
ROE
— 19.55% 34.00% (46.50%) (14.07%) (23.07%) (86.34%) (52.27%) (33.93%)
ROA
— 0.00% (34.88%) (23.92%) (12.49%) (20.31%) (74.72%) (40.59%) (25.19%)
ROIC
— 0.00% 0.00% (69.84%) (21.76%) (31.62%) (400.00%) (154.63%) (100.51%)
Return on Tangible Assets
— (24.73%) (72.89%) (22.53%) (25.63%) (52.66%) (189.46%) (100.99%) (55.10%)
Average Days of Receivables
— 99.29 80.25 67.41 74.18 76.86 76.29 103.15 72.75
Research and Development Expense of Revenue
— 31.83% 36.24% 34.42% 42.17% 49.96% 40.85% 33.84% 29.22%
Selling, General and Administrative Expense of Revenue
— 60.42% 68.44% 90.25% 63.60% 82.25% 82.26% 77.62% 52.67%
Intangible Assets out of Total Assets
0.00 0.00 0.51 0.18 0.41 0.47 0.20 0.23 0.20
Share Based Compensation of Revenue
— 6.73% 8.15% 48.26% 18.42% 28.43% 27.89% 18.69% 8.83%
Graham Net Nets
— 0.20 0.20 0.39 0.42 0.64 0.83 1.81 2.17
Graham Number
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
— (2.56%) (2.56%) (9.02%) (11.42%) (34.75%) (165.52%) (193.10%) (121.18%)
Free Cash Flow Yield
— (14.29%) (14.29%) (4.62%) (9.26%) (26.22%) (39.69%) (131.09%) (83.73%)
Revenue per Share
— 56.16 72.37 49.53 19.90 20.22 18.23 16.96 15.54
Operating CF per Share
— (36.47) (39.81) (22.71) (11.14) (14.03) (10.44) (8.49) (4.11)
Capex per Share
— (0.94) (0.65) (0.67) (0.04) (0.76) (1.07) (1.01) 0.00
Free Cash Flow per Share
— (37.41) (40.46) (23.38) (11.19) (14.79) (11.51) (9.50) (4.11)
Cash per Share
— 128.62 86.35 210.55 58.76 39.28 26.18 15.22 11.36
Shareholders Equity per Share
— 0.00 (136.54) 251.65 99.25 79.06 33.79 21.08 15.44
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— 0.00 (136.54) 251.65 99.25 79.06 33.79 21.08 15.44
Free Cash Flow
— (75.92) (83.23) (115.78) (142.10) (202.77) (163.59) (142.56) (65.97)
Working Capital
— 210.00 116.95 992.31 685.67 512.56 355.79 205.73 173.47
Capital Expenditures
— (1.91) (1.34) (3.32) (0.56) (10.45) (15.25) (15.22) (0.02)
Net Current Asset Value
— 298.00 (557.22) 982.84 642.34 492.91 340.06 197.27 170.68
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 0.55 0.98
Capex to Sales
— 0.02 0.01 0.01 0.00 0.04 0.06 0.06 0.00
Price to Operating Income
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
— 2.17 3.58 3.24 8.41 28.13 822.87 95.45 167.12
Cash ROIC
— (29.09%) 80.62% (5.06%) (7.08%) (12.50%) (19.20%) (26.18%) (15.34%)
Accounts Receivable Turnover
— 3.56 4.67 6.29 5.23 5.05 4.60 4.04 4.10
Accounts Payable Turnover
— 10.66 15.23 25.49 16.54 16.55 27.15 31.46 34.95
Inventory Turnover
— 19.54 26.20 25.64 17.83 19.72 21.35 32.68 57.59
Average Days of Payables
— 24.91 29.68 13.50 29.88 16.46 10.81 11.78 5.17
Days of Inventory on Hand
— 18.68 14.17 21.25 18.51 19.88 14.78 6.71 3.72
Average Receivables
— 32.00 31.87 39.01 48.34 54.87 56.26 63.02 60.79
Average Payables
— 5.50 5.25 6.15 8.98 9.70 6.05 4.94 3.33
Average Inventory
— 3.00 3.05 6.12 8.33 8.13 7.69 4.76 2.02
Average Assets
— 0.00 249.94 938.26 1,411.24 1,331.70 903.63 512.84 379.88
Average Common Equity
— (269.50) (256.43) 482.67 1,253.54 1,172.36 782.02 398.22 282.02

Fold the line items

Columns are period end dates